ShammasNW.
Dethrombosis of the lower extremities. Pharmacologic and
mechanical techniques. Vascular Disease
Management.
2006;May/June:235–239.
3.
OurielKVeithFJSasaharaAA.
A comparison of recombinant urokinase with vascular surgery
as initial treatment for acute arterial occlusion of the legs. Thrombolysis
or Peripheral Arterial Surgery (TOPAS) Investigators.
N Engl J Med.
1998;338:1105–1111.
4.
WissgottCRichterAKamusellaP. Treatment of critical limb ischemia
using ultrasound-enhanced thrombolysis (PARES trial): final
results. J Endovasc Ther.
2007;14:438–443.
5.
BaganPDakhilBLacalP. Acute peripheral arterial occlusion:
prospective study evaluating intra-arterial thrombolysis with a micro-porous
balloon catheter. J Endovasc Ther.
2013;20:422–426.
6.
ShammasNWWeissmanNJCoinerD. Dethrombosis of lower extremity
thrombus by local delivery of thrombolysis using ClearWay transcatheter
balloon irrigation: a feasibility study. Cardiovasc
Revasc Med.
2011;12:350–354.
7.
ShammasNWShammasGADippelEJ. Predictors of distal embolization in
peripheral percutaneous interventions: a report from a large peripheral
vascular registry. J Invasive Cardiol.
2009;21:628–631.
8.
AnselGMGeorgeBSBottiCF. Rheolytic thrombectomy in the
management of limb ischemia: 30-day results from a multicenter
registry. J Endovasc Ther.
2002;9:395–402.
9.
ShammasNWWeissmanNJCoinerD. Treatment of subacute and chronic
thrombotic occlusions of lower extremity peripheral arteries with the
excimer laser: a feasibility study. Cardiovasc
Revasc Med.
2012;13:211–214.
10.
WissgottCKamusellaPRichterA. Mechanical rotational thrombectomy
for treatment thrombolysis in acute and subacute occlusion of
femoropopliteal arteries: retrospective analysis of the results from 1999 to
2005. Rofo.
2008;180:325–331.
11.
AllieDEHebertCJLirtzmanMD. Novel simultaneous combination
chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb
ischemia: the power-pulse spray technique. Catheter
Cardiovasc Interv.
2004;63:512–522.
12.
GuptaRHennebryTA.
Percutaneous isolated pharmaco-mechanical
thrombolysis-thrombectomy system for the management of acute arterial limb
ischemia: 30-day results from a single-center experience.
Catheter Cardiovasc Interv.
2012;80:636–643.
13.
NordtTKMoserMKohlerB. Augmented platelet aggregation as
predictor of reocclusion after thrombolysis in acute myocardial
infarction. Thromb Haemost.
1998;80:881–886.
14.
MerliniPABauerKAOltronaL. Thrombin generation and activity
during thrombolysis and concomitant heparin therapy in patients with acute
myocardial infarction. J Am Coll Cardiol.
1995;25:203–209.
15.
CAPRIE Steering Committee.
A randomised, blinded, trial of clopidogrel versus aspirin in
patients at risk of ischaemic events (CAPRIE). CAPRIE Steering
Committee. Lancet.
1996;348:1329–1339.
16.
ShammasNW.
Bivalirudin: pharmacology and clinical
applications. Cardiovasc Drug Rev.
2005;23:345–360.
17.
AllieDEHebertCJLirtzmanMD. A safety and feasibility report of
combined direct thrombin and GP IIb/IIIa inhibition with bivalirudin and
tirofiban in peripheral vascular disease intervention: treating critical
limb ischemia like acute coronary syndrome. J
Invasive Cardiol.
2005;17:427–432.
18.
DudaSHTepeGLuzO. Peripheral artery occlusion:
treatment with abciximab plus urokinase versus with urokinase alone–a
randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in
Order to Manage Peripheral Artery Thrombosis.
Radiology.
2001;221:689–696.